The impact of conventional versus robust norming on cognitive characterization and clinical classification of MCI and dementia.


Journal

Journal of neuropsychology
ISSN: 1748-6653
Titre abrégé: J Neuropsychol
Pays: England
ID NLM: 101468753

Informations de publication

Date de publication:
03 2023
Historique:
received: 08 09 2021
accepted: 22 07 2022
pubmed: 21 9 2022
medline: 14 3 2023
entrez: 20 9 2022
Statut: ppublish

Résumé

We examined the impact of conventional versus robust normative approaches on cognitive characterization and clinical classification of MCI versus dementia. The sample included participants from the National Alzheimer's Coordinating Center Uniform Data Set. Separate demographically adjusted z-scores for cognitive tests were derived from conventional (n = 4273) and robust (n = 602) normative groups. To assess the impact of deriving scores from a conventional versus robust normative group on cognitive characterization, we examined likelihood of having a low score on each neuropsychological test. Next, we created receiver operating characteristic (ROC) curves for the ability of normed scores derived from each normative group to differentiate between MCI (n = 3570) and dementia (n = 1564). We examined the impact of choice of normative group on classification accuracy by comparing sensitivity and specificity values and areas under the curves (AUC). Compared with using a conventional normative group, using a robust normative group resulted in a higher likelihood of low cognitive scores for individuals classified with MCI and dementia. Comparison of the classification accuracy for distinguishing MCI from dementia did not suggest a statistically significant advantage for either normative approach (Z = -0.29, p = .77; AUC = 0.86 for conventional and AUC = 0.86 for robust). In summary, these results indicate that using a robust normative group increases the likelihood of characterizing cognitive performance as low. However, there is not a clear advantage of using a robust over a conventional normative group when differentiating between MCI and dementia.

Identifiants

pubmed: 36124357
doi: 10.1111/jnp.12289
pmc: PMC10006397
mid: NIHMS1845900
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-124

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066518
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : Alzheimer's Association
ID : 2019-AARF-641693
Pays : United States

Informations de copyright

© 2022 The British Psychological Society.

Références

J Int Neuropsychol Soc. 2007 May;13(3):490-500
pubmed: 17445298
J Gerontol B Psychol Sci Soc Sci. 1996 Jul;51(4):P217-25
pubmed: 8673642
Alzheimers Dement. 2016 Mar;12(3):292-323
pubmed: 27012484
Neuropsychology. 2008 Jul;22(4):469-84
pubmed: 18590359
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6
pubmed: 17132964
J Neuropsychol. 2021 Sep;15(3):410-427
pubmed: 33655681
J Consult Clin Psychol. 1999 Jun;67(3):285-99
pubmed: 10369049
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
Alzheimers Dement. 2020 Mar 10;:
pubmed: 32157811
J Int Neuropsychol Soc. 2013 Mar;19(3):272-83
pubmed: 23298442
Neuropsychology. 2020 Sep;34(6):629-640
pubmed: 32338945
Mayo Clin Proc. 2014 Oct;89(10):1452-9
pubmed: 25282431
J Am Geriatr Soc. 2018 Jul;66(7):1360-1366
pubmed: 29745971
Arch Clin Neuropsychol. 2020 Jul 21;:
pubmed: 32710607
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Int Neuropsychol Soc. 2020 Jul;26(6):576-586
pubmed: 32063246
J Int Neuropsychol Soc. 2008 May;14(3):463-78
pubmed: 18419845
Aging (Milano). 1996 Dec;8(6):379-85
pubmed: 9061124
Clin Neuropsychol. 2007 Dec;21(6):863-74
pubmed: 17853155
Alzheimers Res Ther. 2011 Nov 11;3(6):32
pubmed: 22078663
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358
pubmed: 30376508
Neurology. 2012 Jun 5;78(23):1886-91
pubmed: 22665145
Arch Clin Neuropsychol. 2016 Nov 22;31(7):675-688
pubmed: 27193363
Arch Clin Neuropsychol. 2008 Sep;23(5):531-41
pubmed: 18572380
Neurology. 2004 Dec 28;63(12):2341-7
pubmed: 15623697
Biling (Camb Engl). 2012 Jul;15(3):594-615
pubmed: 25364296
Neurobiol Aging. 2016 Jul;43:23-33
pubmed: 27255812
Alzheimer Dis Assoc Disord. 2007 Jul-Sep;21(3):249-58
pubmed: 17804958
Alzheimer Dis Assoc Disord. 2020 Jul-Sep;34(3):191-197
pubmed: 32483017
Clin Neuropsychol. 2003 Feb;17(1):19-33
pubmed: 12854008
Neurobiol Aging. 1996 Jan-Feb;17(1):123-30
pubmed: 8786794
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Arch Neurol. 2011 Mar;68(3):351-6
pubmed: 21403020
J Alzheimers Dis. 2018;64(1):195-204
pubmed: 29865077
Neuropsychologia. 2011 Jan;49(1):43-8
pubmed: 21029744
Arch Clin Neuropsychol. 2010 Aug;25(5):347-58
pubmed: 20427376
Alzheimers Dement (Amst). 2015 Dec 19;2:12-8
pubmed: 27239531
Int Psychogeriatr. 1997;9 Suppl 1:173-6; discussion 177-8
pubmed: 9447441
Psychogeriatrics. 2021 Jul;21(4):491-502
pubmed: 33890392
Arch Clin Neuropsychol. 2019 Jan 24;35(1):75-89
pubmed: 31236576
Assessment. 2021 Sep;28(6):1735-1750
pubmed: 32483976
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
J Clin Exp Neuropsychol. 2015;37(10):1098-106
pubmed: 26325449
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132

Auteurs

Alyssa N Kaser (AN)

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

David M Kaplan (DM)

Department of Economics, University of Missouri, Columbia, Missouri, USA.

William Goette (W)

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Andrew M Kiselica (AM)

Department of Health Psychology, University of Missouri, Columbia, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH